DMAC
DiaMedica Therapeutics Inc. · Healthcare
Chief Business Officer David J. Wambeke bought $150K of DiaMedica Therapeutics Inc.
Bought$150,003
$3.91Price
38,364Shares
+8%Stake
What DMAC did for a copier
- $1,000 copied at Mon, Jun 26 close, $4.40
- $702
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Aug 8 close.
David J. Wambeke's record
3 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Jun 23. Filed Mon, Jun 26, 12:14 PM ET, during the session. Returns use the Jun 26 close and the Aug 8 close. Not investment advice.